Clinical trials
Withdrawn Prostatic Neoplasms trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
72 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 3 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 9 |
| 2013 | 1 |
| 2014 | 7 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 7 |
| 2018 | 2 |
| 2019 | 7 |
| 2020 | 2 |
| 2021 | 7 |
| 2022 | 4 |
| 2023 | 7 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 72 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Case Comprehensive Cancer Center | 10 |
| Stanford University | 3 |
| Wake Forest University Health Sciences | 3 |
| Chinese University of Hong Kong | 2 |
| Duke University | 2 |
| Jonsson Comprehensive Cancer Center | 2 |
| Roswell Park Cancer Institute | 2 |
| University of Southern California | 2 |
| Abramson Cancer Center at Penn Medicine | 1 |
| Albert J. Chang | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prostatic Neoplasms | 72 |
| Breast Neoplasms | 3 |
| Carcinoma, Renal Cell | 3 |
| Urinary Bladder Neoplasms | 3 |
| Urinary Incontinence | 3 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Neoplasm Metastasis | 2 |
| Neoplasms | 2 |
| Anxiety Disorders | 1 |
| Carcinoma, Ovarian Epithelial | 1 |
Trials
Showing 1 to 25 of 72. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.